Supplemental Tables from Prediagnostic Circulating Anti-Müllerian Hormone Concentrations Are Not Associated with Prostate Cancer Risk

Supplemental Tables. Supplemental Table 1. Baseline characteristics by AMH quartiles. Supplemental Table 2. Baseline characteristics by AMH quartiles restricted to controls only. Supplemental Table 3. Spearmen correlations between circulating AMH levels and androgens in overall and control men with androgen measurements. Supplemental Table 4. Sensitivity analysis: Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for AMH quartiles and prostate cancer risk sequentially excluding prostate cancer cases who were diagnosed within two, three and then five years after sera collection. Supplemental Table 5: Sensitivity analyses: Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for AMH quartiles and prostate cancer risk. Supplemental Table 6. Sensitivity analysis: Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for AMH quartiles and prostate cancer risk restricted to subpopulation with PSA at T0